冠動脈外科手術が,無症状および症状がほとんどない患者の生存に与える影響
Circulation
|August 1, 1980
まとめ
冠動脈サフェノスバイパス移植手術は,機能的クラスIおよびIIの疾患を有する患者の生存率を改善する傾向を示しました. しかし,三血管冠動脈疾患の患者だけが,手術後の生存率を大幅に改善しました.
科学分野:
- 心血管外科手術についてです.
- 介入性心臓病学 介入性心臓病学
- クリニカル・アウトカム・リサーチ 研究結果
背景:
- 冠動脈疾患 (CAD) は,世界中で数百万人に影響を与え,効果的な治療戦略を必要とします.
- 冠動脈サフェノスバイパス移植手術は,重度のCADの一般的な介入です.
- 特定の患者のサブグループにおけるバイパス手術の長期的な生存効果を評価することは,治療ガイドラインの決定的なものです.
研究 の 目的:
- 冠動脈サフェノスバイパス移植手術の生存への影響を評価する.
- 機能的クラスIおよびIIの冠動脈疾患を有する患者の生存結果を分析する.
- 病気の血管の数が外科手術の生存効果に影響するかどうかを判断する.
主な方法:
- シアトル・ハート・ウォッチ・コホートから619人の患者を対象とした前向きな研究.
- ベースラインの特徴的差異を調整するためにコックスの回帰分析を使用した.
- 影響を受けた冠動脈の数 (一,二,または三本の血管) に基づくサブグループ分析.
主要な成果:
- 全体として,手術による治療は,生存率の統計的に有意な改善を示した (p = 0.069).
- 三血管疾患の患者はバイパス手術後の生存率が有意に改善したことを示した (p = 0.017).
- 一血管性 (p = 0.758) または二血管性疾患 (p = 0.324) の患者では,生存に有意な利点は見られなかった.
結論:
- 冠動脈サフェノスバイパス移植手術は,冠動脈疾患の特定の患者にとって生存上の利点をもたらす可能性があります.
- バイパス手術の生存に対する利点は,三血管疾患の患者において最も顕著である.
- 更に研究が進めば,冠動脈バイパス移植手術で最適な結果を出すために患者の選択を洗練することができる.
さらに関連する動画
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
関連する概念動画
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
